Good morning.
Futures green across the board, S&P +0.6%, NDX flat-ish — but the internals tell a different story. Massive rotation out of semis into hyperscalers and SaaS. MU -10%, erased $110B in market cap. AAPL +$185B on China AI approval. PYPL +16.8% on Stripe/Advent bid. Breadth horrid otherwise.
ASML is the marquee print — raised guidance for the second time this year, memory revenue growing +75% in 2026, 2027/28 revenue estimates lifted to €56B/€72B. Stock opened +8% then closed flat at LOD. That's the tape telling you something. The guide is spectacular. The positioning was already long.
Asia mixed. Tokyo semis catching up to the US rotation — Tokyo Electron down, Advantest weak. Soft US PPI (June +5.5% vs +6.2% est.) crushed July hike odds to 4%. DXY toward 100.50, 2yr yields -6bp. USD weakness is the meta-trade right now.
Three themes framing the day:
1. The Rotation is Real, Not a Blip. Hyperscalers catching bids while semis bleed is a positioning unwind, not a fundamental call. Buffett publicly validating Google's AI ROIC. MSFT accelerating Azure capacity in Q3. OAI ARR at $50B. The narrative shifted from "capex bubble" to "ROI validation" in 72 hours. We're selling the semi strength into the guide and buying the hyperscaler dip.
2. Memory Panic is a Gift. MU, SKHY, SNDK down 30%+ in two weeks. Zero fundamental change. This is trailing stops hitting on a mechanical drawdown after a 6-month parabolic run. The ASML guide CONFIRMS memory WFE growing 75% in 2026. KV cache offloading driving NAND demand. DRAM substitution trend emerging. Risk/reward is now favorable for the AI-levered memory names. Not a sector — it's a thesis.
3. The Power Bottleneck is the New Beta. Google backstopping $50B in datacenter commitments. New York governor blocking builds while approving fabs. Virginia datacenters generating $40B in economic impact. Gas turbines winning on speed-to-power. This is a multi-year infrastructure cycle that hyperscalers cannot avoid. Contrarian call: gas turbine orders may peak this year, but the buildout doesn't stop. DLR, WMB, CLSK are the long-duration plays here.
4. Open Source is Crushing the Gap. Thinky, Kimi K3, Inkling (975B open weights) — new frontier models dropping weekly. Grok Build open source. This drives inference demand higher, not lower. NVFP4 checkpoint support out of the gate. Great for NVDA, ARM, the entire compute stack. Bad for proprietary model margins.
We'll hit up ASML and the semicap group first, then dig into the memory names ahead of TSM/NFLX prints. After that, we're on hyperscalers and the power thesis.
CLSK IS NO LONGER A BITCOIN MINER. Period.
That's the take from the 5 analyst notes this morning covering the Sandersville 20-year HPC lease. The consensus is a unanimous Strong Buy with PTs ranging $16 to $27 — but the effective cluster is $22-$26, with Cantor and Needham both raising to $26 and $23 respectively from a prior $17-$18 range. Street sees 64-94% upside from the $13 handle.
The build-to-suit triple-net lease with an investment-grade global tech tenant at the 175MW Georgia site should generate $330M annualized revenue at near-100% NOI margins. Base contract value is $6.6B, rising to $11.6B if two 5-year options get exercised. First delivery targeted for Q4 2027.
"This is the primary re-rating catalyst we've been waiting for. The tenant is high-investment-grade and the economics validate the digital infrastructure thesis." - Clear Street
BUT — and this is where the nuance lives — the tenant is STILL undisclosed, and the transaction isn't hitting cash flows until late 2027. This is a story stock. For now.
What's NEW: The Sandersville contract pricing implies ~$1.9M/MW/yr, a premium to recent Terawulf/Hut 8/Cipher leases that landed in the $1.7-$1.8M range (BTIG). Needham notes the NOI/MW comes "modestly lower" than those peers — so call it a mixed bag on relative economics. The capital plan matters: $1.93B total capex, with 80-90% project-level debt at ~6% interest rate (BTIG, H.C. Wainwright). That's an 11-12% unlevered return.
What's INCREMENTAL and matters more than the Georgia deal: The tenant also holds a letter of intent and exclusivity on CleanSpark's ENTIRE 885MW Texas portfolio across Sealy (~300MW) and Brazoria (300MW expandable to 600MW pending ERCOT). Cantor says CLSK "could be close to signing another, larger lease" — possibly within 30-120 days (Needham). If Texas gets contracted at similar ~$1.9M/MW pricing, that's another $1.15B+ incremental annual revenue (H.C. Wainwright math).
What's ALREADY KNOWN: The BTC mining thesis. June production was 614 BTC, holdings now 13,924 (~$878M at spot). Management stopped spending capex on mining "several quarters ago" (Cantor). That BTC treasury is now explicitly framed as financing optionality for the HPC buildout.
One risk flag: Cantor flags that ~1/3 of CLSK's Texas power faces ERCOT-related risk, though management is confident their sites qualify as Batch 0 Firm.
BULL CASE ($26-$27, Cantor/BTIG/Citizens): This is a transformative re-rating from commodity miner to contracted digital infrastructure. The 20-year cash flow visibility, investment-grade counterparty, and 100% NOI margins justify a massive multiple expansion. The BTC treasury provides equity-light financing optionality. If Texas gets contracted at similar terms — and the LOI suggests it's likely — you're looking at $1.5B+ of annual EBITDA power by 2028-2029. Cantor explicitly says "this is a pivotal step" and expects multiple additional leases. The premium pricing vs. peers signals strong demand for CLSK's power position.
BEAR CASE (implicit): The tenant is anonymous. The market is pricing this as if it's a hyperscaler, but we don't actually know. Construction risk is real — this is $1.93B of capex execution on a company with $1.79B total debt and a market cap barely above $3B. The 80-90% LTC financing assumption may be optimistic if rates stay elevated. Needham admits the NOI/MW is "modestly lower" than Terawulf and Hut 8 comps. And the BTC mining business is still a drag on the story — production numbers are fine (20.5 BTC/day) but mining margins are under pressure industry-wide. This stock is pricing a perfect execution scenario two years out. You're paying for optionality.
This validates the entire bitcoin miner-to-AI infrastructure transition narrative. CLSK's premium pricing vs. Terawulf/Hut 8/Cipher is a bullish signal for the subsector — suggests demand for available power is accelerating, not peaking. If CLSK can contract 885MW in Texas at these terms, it implies the power-constrained hyperscaler thesis is alive and well.
Keep an eye on RIOT and MARA this morning — they both have meaningful power positions that could be next for HPC re-rating. WULF and BITF similarly. The read-through is: power is the asset, not the mining rig. CLSK is the first to prove it at scale with an investment-grade counterparty.
The real catalyst to watch isn't the Georgia buildout — it's whether the Texas LOI converts to a signed lease within the 30-120 day window Needham flagged. That would be the next leg up.
Verdict: The AI overhang is a buying opportunity, but Q2 needs to deliver. Oppenheimer is leaning hard into the multiple expansion narrative, calling the AI disruption fears "overdone." UBS is politely skeptical — stable demand, no material improvement in tone around AI, just a modest beat. This is a setup where the bull case is about the 2030 targets and 10%+ AI revenue mix by year-end 2026, and the bear case is that the re-rate won't happen on a tepid guide. NOW at $104.85, down 27% YTD. The re-rate story lives or dies on July 22.
Oppenheimer raised to $140 (from $130), Outperform. UBS went to $115 (from $100), Neutral. Truist bumped to $130 earlier. Evercore and Bernstein still at $150 and Outperform.
"AI disruption concerns on ServiceNow carry some risk to future growth but are overdone given the company’s workflow automation platform, proprietary data, deep enterprise integration, and growing AI business." — Oppenheimer
Oppenheimer is leaning into the margin story too: 76.6% gross margin, disciplined hiring, AI efficiency driving margin expansion. They see multiple expansion when software sentiment turns. UBS checked customer/partner pulse — demand stable but not improving, AI tone "not significantly improved." They expect only modest upside to guidance, not enough to re-rate a 62.7x P/E.
Bull case: NOW owns the enterprise workflow layer. Proprietary data + deep integration = moat that survives AI disruption. AI revenue mix hitting 10%+ by year-end 2026, combined with 2030 financial targets, gives a long-duration growth story at a compressed multiple. Q2 prints above consensus, AI commentary strong, margins expand. Re-rate incoming.
Bear case: Premium multiple (63x) leaves no room for error. Demand stable, not accelerating. AI narrative is already priced in — UBS feedback shows no step-change in customer excitement. A "modest beat" won't move the needle. Stock stays range-bound until actual AI revenue acceleration materializes in 2H26.
Verdict: Trainwreck quarter, stock -28%. The bull case isn't dead, but it's on life support. Oppenheimer flipped to Perform, Evercore holding the line at Outperform. The preannouncement was brutal — $17.2B vs $17.9B consensus, $2.93 vs $3.02. Every segment missed, and management blamed Transaction Processing weakness, memory-driven buying shifts, and end-of-quarter deal slippage. The stock is now at $217, a hair above the 52-week low.
Infrastructure -7% YoY (street expected -3%). Software +5% (street ~+10%). Consulting flat. The bright spots: RedHat accelerated to +11% CC, HashiCorp and Confluent "strong." Distributed Infrastructure +37% on POWER and storage. But mainframe software stack (Transaction Processing) — the cash cow — is coughing.
Oppenheimer (now Perform) called the preannouncement "negative" and said it'll be "difficult for IBM to meet its full-year guidance or achieve double-digit constant currency software growth for CY26 and CY27." They see the stock range-bound near-term.
Evercore ISI kept Outperform/$310, arguing the miss is a timing issue — clients pulling forward spending on servers/storage/memory to beat price hikes, plus cybersecurity priorities. They noted the z17 mainframe reached 130% program-to-program vs z16 cycle — that's a positive signal for future quarters.
"The bull thesis will take longer to materialize and we anticipate the stock will be range bound in the near term." — Oppenheimer downgrade note
Bull case (Evercore, holdout Oppenheimer believers): This is a lumpy mainframe transition quarter. RedHat accelerating, HashiCorp/Confluent momentum, Quantum optionality worth ~$65/share per one model. If z17 cycle ramps H2, software growth snaps back. Valuation is cheap-ish: 25.7x P/E with PEG of 0.27. Dividend aristocrat (30-year streak) gives a floor.
Bear case (HSBC downgraded to Reduce/$191, Oppenheimer walking away): Mainframe softness is structural — not just a timing glitch. Software growth <10% makes the full-year guide look impossible. Consulting is dead money. The stock got a 2x+ rerating on AI hopes that aren't materializing in the P&L. At 25x with no top-line growth, there's no margin of safety.
Verdict: BTIG and Freedom Broker both hiked PTs ($237 and $240, respectively) — this is a platform story now, not an endpoint story. Stock at $210, up ~80% YTD, hovering just below the 52-week high. The consensus is hardening: CRWD is the primary beneficiary of AI-driven cybersecurity modernization, and the market is starting to price that in.
BTIG ran field checks with six industry contacts (three partners, two cyber advisory firms, one analyst) plus a pre-quiet period IR call. Two weeks left in FQ2, and they now have "increased confidence" in their outlook. Their upside scenario: 25% ARR growth vs Street 24.4%.
Freedom Broker did European investor meetings with management. Message was consistent — demand broad-based across endpoint, cloud, identity, and next-gen SIEM. They explicitly say the investment case is shifting away from standalone EDR dependency toward a unified platform play. IBM’s preliminary results backed this up (clients pivoting budgets toward cybersecurity).
Both firms raised mid- to long-term revenue growth assumptions. Freedom Broker’s move is notable because they say the quality and durability of growth is improving, not just near-term AIDR acceleration.
Key PT moves post-split: BTIG $237, Freedom Broker $240, UBS $235, Morgan Stanley $172 (still Overweight), Rosenblatt $206 (still Buy). The cluster is $206-$240 — wide but all bullish. The low end (MS, Rosenblatt) seems conservative; the high end is betting on platform scaling.
Bull case: AI tailwinds are real and CRWD is the prime beneficiary. Platform expansion (Next Gen SIEM, Exposure Mgmt, AI Detection & Response) is gaining traction. 75% gross margins, 23% revenue growth, and net income expected to grow this year. Premium valuation justified by market position.
Bear case: At $210 and 80% YTD, valuation is already pricing in a lot of this optimism. If FQ2 ARR comes in at consensus or worse, multiple compression is real. EDR is maturing — platform transition needs to deliver tangible revenue acceleration, not just narrative.
From Freedom Broker’s note (the stronger of the two for platform thesis):
"The investment case increasingly shifts away from reliance on the standalone endpoint detection and response market toward scaling a unified platform amid AI-driven modernization."
That’s the money line. The stock has re-rated on this narrative. Now it needs to deliver.
Verdict: Two houses, two PT moves (Wells -$25 to $625, Evercore +$15 to $525), same long thesis – Azure acceleration and Copilot monetization are the only things that break the stock out of its trading range. The capex debate is now the central tension.
Street is bracing for FQ4 Azure print in the 41% constant currency range – a 1pp beat vs. the 39-40% guide. Wells Fargo sees that as a modest positive, but no one is calling Q4 the inflection point. Evercore explicitly says “do not see the fourth quarter as a major inflection point for the debate on capital expenditure spending.”
Azure acceleration is supposed to show up in H2 CY2026 (their fiscal H1 2027). Copilot seats are tracking: Wells models AT LEAST 26M M365 Copilot seats based on guided net adds of 5M+ in the quarter. Partners cite mid-to-high single-digit adoption within seat bases – real, but not yet a tidal wave.
The headcount cut of ~4,800 (non-core gaming, alignment with prior guidance) is noise. The real story is capex.
Wells revised outer-year capex sharply higher: $45B/GW in FY27-28, over $50B by FY30. FY28 capex raised 13% to $278B. Evercore is even more aggressive on cash capex: ~$210B for FY27 vs. Street at ~$180B. That’s a $30B gap – and it’s not going to resolve in one quarter.
“Shares remain in a trading range as different investor groups await clarity on Azure revenue acceleration and Copilot monetization.” — Evercore ISI
Translation: Bull camp needs to see revenue catch up to the spend. But with PEG at 0.77 (trailing 17.9% rev growth, $384 stock), the valuation is pricing in zero margin for error on the return side.
Forward revenue multiple on FY27 Street estimates roughly 8.5x (using $225B+ revenue). At PEG 0.77 – that’s a growth stock priced like a value trap. The debate is whether the spend is building a moat or burning cash. Two analysts, same long tone, different price targets – tells you the range of outcomes is still wide.
Verdict: Japan capacity news is the missing piece investors needed. The stock ripped 18% last week on this — and Benchmark thinks there’s another 30% upside from here.
Cody Acree (Benchmark) is out reiterating Buy and $335 PT, but the interesting part is why. He frames the Japan announcement as the direct answer to the key investor debate: can TSEM convert its AI-infra silicon photonics / SiGe pipeline into actual committed 300mm capacity with subsidy support and funding visibility? The answer, apparently, is yes. Gross $4B two-phase Japan project, backed by a $1B METI subsidy and $1.5B of existing cash on the balance sheet. That’s real.
Benchmark had already bumped the PT from $230 to $335 back when TSEM printed $1.3B of contracted FY27 silicon photonics revenue with $290M in customer prepayments. Now they’re layering in the capacity story. The stock closed Friday at $261, so the implied r/r is still decent — but the rate of change on the narrative is accelerating.
"The update addressed the key investor debate about whether the company’s AI-infrastructure opportunity can be converted into committed 300mm specialty-foundry capacity with sufficient subsidy support and funding visibility to justify a higher fiscal 2028 earnings framework."
The only real caveat: this is a single-broker reiteration, not a wave of upgrades. TSEM is thinly covered so a single voice carries weight, but we’d want to see the broader Street bake in the FY28 framework before getting overly excited. Still — the Japan news is a tangible step, not just slides.
China AI approval clears the biggest overhang. Evercore ISI holds at Outperform / $365 following Beijing’s sign-off on Apple’s on-device gen AI service. This is the localized version — Alibaba’s Qwen across iOS/iPadOS/macOS/visionOS, Baidu confirmed as the underlying tech. Stock already near the 52-week high ($324.64) and up 51% in the last year. The bull case just got a fresh gear.
The remaining regional headache is Europe — Siri AI won’t hit iOS 27 or iPadOS 27 in the EU due to DMA concerns. That’s a known drag, not a new one.
Analyst consensus is messy. Monness Crespi Hardt upgraded to Buy / $335, KeyBanc went Underweight on iPhone production fears. Meanwhile global smartphone shipments hit a 13-year low — but Apple gained share, now at 20% with 3% unit growth. Counterpoint expects price hikes ahead.
Event horizon: Q3 fiscal 2026 earnings July 30 — Tim Cook’s last call before Ternus takes over Sept 1. The lawsuit against OpenAI (trade secret misappropriation) is background noise for now. Focus is on whether China AI monetization offsets EU friction.
Buy the ecosystem, not just the switch. Erste upgrades to Buy from Hold, and the street is piling on — Wolfe Outperform, TD Cowen Buy, Piper Overweight. The bull case is straightforward: Arista owns the control plane for AI networking with its vendor-agnostic EOS, and that’s sticky at scale. Revenue growth 31% LTM, gross margin 64%, operating margin crushing peers. Q2 guide of $2.8B came in above consensus.
"Arista Networks is building a vendor-agnostic ecosystem that enables control and coordination between AI networks and AI computing infrastructure." — Hans Engel, Erste Group
The bear whisper (Piper flagged peak growth and de-commitments) is real but hasn’t broken the tape yet. At $218B market cap and a 70% return in the rearview, the multiple is priced for continued acceleration in hyperscaler spend — not a flattish 2027. If you believe the 1.6T 7060XE7 cycle pulls forward demand, r/r still works. If not, you’re late. PMs should watch the next hyperscale capex prints for the rate of change signpost.
DA Davidson goes bold on DT. PT to $60 from $45 (32% upside to current $45.38). Thesis: ARR acceleration is achievable despite a soft Q4 print. AI tailwinds in observability are real. Stock already +14% over 6M.
"The firm expressed confidence that annual recurring revenue acceleration remains achievable over the course of the year for Dynatrace."
Broader Street mixed but constructive — UBS also at $60, BMO at $50, Stifel stuck at $41. FedRAMP High push and Starboard engagement add strategic optionality. Not sure the FY27 guide is de-risked yet, but the narrative is shifting toward AI adoption. Worth a look if you buy the acceleration story.
Cantor holds the line at $450 with Overweight, calling the 111% runner a multi-year compounder. You don't get many names up 43% YTD where the bull case actually accelerates from here, but AEIS is threading the needle — semi equipment cycle (front-end WFE +30% in CY26) AND data center power architecture upgrade (800-volt transition). Cantor thinks management lowballed the guide. Upside in both segments.
Blockquote for the core conviction:
"Cantor Fitzgerald expects the company’s positioning in the 800-volt transition to drive performance. Management set conservative guidance last quarter, with upside likely in both business segments."
The numbers ladder up nicely: CY26 EPS closer to $10 (street at $9.39). By CY28 Cantor sees $20 if semi compounds at ~25% and data center at ~30%. That's a double-digit multiple on a high-growth industrial story — not cheap but the trajectory is real.
Caveats? Big debt move — $1.15B zero-coupon convert due 2031, retired $438M of the 2028s. Creative balance sheet management, but dilution looms if the stock stays below conversion. The new ADH series DC-DC converters (98.2% peak efficiency) show they're playing the AI power game, not just semi tools.
One name, one analyst, one clear narrative. If you believe the semi cycle has legs and the power infrastructure trade isn't done, AEIS is a compounder with a catalyst path. If you don't, the multiple is already pricing a lot of perfection.
Guggenheim upgrades to Buy from Neutral at $200. The call is about scarcity value — with new construction getting harder, owning the existing footprint is the edge. Osha cites Q2 setup as constructive (renewal spreads improving, sub-1MW momentum intact).
"We view owning a data center REIT with established properties as beneficial given current building constraints."
The $7.8B Northern Virginia acquisition from Blackstone (closed via $1.2B cash + $2.3B shares) is the obvious catalyst — adds 288MW of fully leased capacity in the tightest market in North America. Stifel, BMO, Bernstein all reiterated Buy/Outperform in the wake of that deal (PTs $220-235). The stock at $173 still offers ~15% upside to the new Guggenheim target, and ~30% to the Street high.
Not going to pretend the 1MW+ lumpiness doesn’t exist — Osha himself is “tempered” on that. But the combination of existing supply, AI leasing demand, and a balance sheet that just got bigger and better-located makes the risk/reward attractive here.
Verdict: Stifel doubling down ahead of the print, and the setup is actually getting cleaner. They’re reiterating Buy / $110 (68.1x CY27 P/E) with conviction that max upside is now driven by a raised CY26 optical guide, the 1.6T ramp accelerating, and — most importantly — a potential SIMO arbitration resolution that could clear a multi-year overhang.
The quarter itself looks beat-and-raise. Stifel expects June rev/eps to exceed the Street’s $164.6M / $0.33, with all four end markets growing sequentially and Infrastructure leading. For September they see guide above the $173.9M / $0.38 consensus. The stock is already up 543% in the last twelve months (trades $92.59), so this is a momentum name where the rate of change keeps going the right direction.
“The arbitration update could remove a multi-year overhang on the stock.”
The bull case here is straightforward: Optical / data center momentum is real, the 1.6T transition is accelerating, and the SIMO arbitration is a binary de-risk event that could unlock the next leg. The bear case? 68x forward P/E leaves zero room for error — any guide miss or delay in the arbitration ruling and this thing gets shredded. But for now, the rate of change in the fundamentals beats the valuation debate.
Erste Group downgraded MRVL to Hold from Buy, and it's the first notable sell-side pushback after a 208% run in 12 months. The call isn't about deteriorating fundamentals — Q2 revenue guide of $2.7B (+35% y/y) and EPS ~$0.93 are fine — but valuation and concentration risk. P/E of 73.6x is well above industry average, even if the PEG ratio (0.13) screams "cheap relative to growth." That PEG is a trap when growth is narrowly sourced.
"A sustained increase in the operating margin appears uncertain because the company is heavily dependent on a small number of customers."
That single sentence is the bear case in a nutshell. MRVL's customer concentration (Nvidia et al.) creates a binary revenue profile — great when hyperscalers are building, ugly if anyone pulls back. Meanwhile, operating income growth isn't keeping pace with topline, so margin expansion is a question mark.
Counterpoint: other analysts see it differently. UBS and B.Riley just lifted PTs to $340-345, eyeing CXL technology and the Nvidia partnership as multi-year growth drivers. The Erste downgrade is the first crack in the consensus, but not a rout. PMs should watch for follow-ups — if more houses pivot, the 73x multiple becomes a liability real fast. Right now it's a battle between "too far too fast" and "still early in the AI infrastructure buildout."
Verdict: the 12% intraday flush on the CoreWeave hedging headline is noise. Evercore ISI is holding Outperform / $500, and their channel work says DRAM/NAND/HBM stays tight through 2027 — not exactly a bull case for big price drops. CoreWeave hasn't even executed anything; they're "exploring" put options on memory chips. That's a nothingburger for a server OEM that benefits from lower component costs if they actually materialize.
The real story: Evercore's checks point to supply constraints worsening exiting 2026 and running through most of 2027. If memory pricing eventually softens, that’s a tailwind for system affordability and delayed enterprise deployments. The sell-side knows this — one firm’s $500 PT is unchanged, and they’re explicitly calling the CoreWeave report a non-event for the thesis.
"We do not view the CoreWeave report as a near-term negative change to our thesis, as checks and memory supplier commentary continue to point to constrained DRAM, NAND and HBM supply through 2027."
Net net: DELL’s selloff was a Bloomberg-terminal knee-jerk on a Reuters rumor. PMs should buy the dip if they need exposure to the AI server build-out. The memory cycle is still the bottleneck, not a glut.
Verdict: Consensus long getting crowded but the story is still building. ONTO ripped 207% in a year to $321, yet the Street sees more runway — 7 upward revisions in the last month alone. Cantor reiterated Overweight/$410, pointing to Dragonfly G5 ($1B TAM) and Iris G2 ($750M TAM) ramping as share gain stories that aren’t fully priced. The kicker: scenario EPS upside to $12/$15 in 2027/2028 from Rigaku MTM accounting and interest income on the convert.
"Scenario earnings power upside to $12 and $15 in 2027 and 2028 respectively."
Oppenheimer went to $450, Freedom Broker/Morgan Stanley/Deutsche all joined with Buy/Overweight ratings in the $350-$371 range. Stifel flagged rapid Dragonfly G5 qualification at "major customers." The bull case is clean — advanced node + advanced packaging tailwinds, multiple product cycles, and a balance sheet lever. The bear case: P/E of 141x trailing. That’s all story, no earnings multiple. But at this rate of change, PMs who bet against the narrative have been burned before. Watch the Q2 print for guidance — that’s the next catalyst.
CANTOR STAYS CONSTRUCTIVE DESPITE THE H2 RAMP RISK. Reiterates Overweight and $600 PT after the stock shed 20% from highs (now $477, 52-week high $616). The thesis hangs on leading-edge metrology intensity, share gains in front-end and advanced packaging, and a long-duration EPS trajectory — Cantor sees $15 in 2027 and $18 in 2028 vs consensus $12.85/$14.56. The near-term bogey: Nova needs to outgrow WFE in 2H, and last quarter it flagged WFE growth of mid-teens vs the complex closer to 25%. That spread needs to close.
"Valuation is not overly demanding today despite questions around near-term expectations within a robust WFE backdrop." — Cantor
Bank of America also chimed in with a $612 PT (from $510) and Buy rating, citing the foundry win for its WMC platform in advanced packaging. Low-30x forward multiple on a 20%+ EPS CAGR story — the r/r works if you believe the H2 ramp is achievable. Risk: it’s not.
STIFEL DOUBLES DOWN — analog cycle has turned. They reiterate Buy with $360 PT (34.7x CY27 P/FCF). Stock already +78% YTD to $299. TXN's core general-purpose analog billings are up 22% YoY, embedded microcontrollers +17%. ISM manufacturing PMI held at 53.3 (sixth straight expansion); Customers' Inventories stayed "too low" at 42.3 — a textbook leading signal for more production.
The real kicker isn't the cycle turn itself — it's the structural capex step-down that creates a free cash flow inflection once the cycle matures. Data center is now a second growth gear. Stifel anchored on the Y/Y trend, not noisy monthly prints.
"We believe the analog cycle has turned, with a structural capital expenditure step-down driving a free cash flow inflection."
One housekeeping note: CFO Julie Knecht takes over Aug 1 (internal promotion, no strategy shift). TXN reports July 22 — options imply a 9.1% swing. PMs should watch for any forward guidance on capex trajectory relative to that step-down thesis.
Raymond James throws cold water on the Check Point narrative. Downgraded to Market Perform from Outperform, citing deteriorating channel checks that contradict the recent noise. The stock has already been cut in third (down 27% in six months) – but the sell-side is now catching up to what the price action was signaling.
The firm is hearing instances of customer churn – that’s a new data point, and a worrying one for a company that sells sticky firewall renewal cycles. Bookings are "down universally," pipeline into 2H is "bleak," and the Q3 rebound everyone hoped for looks unlikely. The new CEO's honeymoon is over: early excitement around Nadav Zafrir fading as operational missteps stack up. Check Point still doesn’t have a credible endpoint product in an AI world where that’s becoming table stakes. Personnel changes are confusing partners – some can’t even execute renewals.
"Bookings are down universally and pipeline into the second half is bleak, making a third-quarter rebound seem unlikely."
The irony? Multiple competitors just got upgraded over the past few weeks. The market was pricing in a turnaround that the channel is now confirming isn’t happening. Guys, this is a show-me story trading on hope – and hope just took a hit.
Verdict: The Blackstone/Apollo data center partnership is the signal we’ve been waiting for. This is Williams monetizing its positioned pipe-to-campus advantage without giving up control or long-term upside. UBS reiterates Buy at $91, Goldman at $82 — both effectively saying the 49% stake sale for $5.34B de-risks the capex curve while leaving WMB with 51% and operational control. Cash distributions aligned to ownership, buyout option between years 7-14. Market likes it: stock up 25.7% YTD, closing in on $80 (52wk high).
"Blackstone and partners providing $4.4B of committed capital for 49% of growth capex — plus $900M consideration to WMB — is a textbook way to fund behind-the-meter power builds without diluting equity or burdening the balance sheet."
Bottom line: This is the rate-of-change catalyst for the power-to-data-center thesis in gas infrastructure. WMB is now trading like a compounder with a growth kicker — 53 years of consecutive dividends and a 2.82% yield don't hurt. The bull case writes itself: re-rate toward the $80s. Bear case? Only if you think the demand signal from Big Tech/AI is a mirage. Not betting against that.
PRINT WAS A FUCKING NUKE. BofA reiterates Buy (PT EUR2,022) after ASML guided Q3 revenue EUR11.5B vs consensus EUR10.4B — that’s an 11% beat on the top line alone. Gross margins guided to 56% vs 52.1% consensus. The real story is the FY26 raise: midpoint EUR44B vs prior EUR36-40B range and EUR39.6B consensus. That’s a 11% beat on full-year revenue. Capacity expansion plans are equally aggressive — EUV capacity going from 65 systems in 2026 to ~110 by 2028. High-NA EUV is now in volume production at Intel for Core Ultra Series 3. The demand narrative is fully intact: 25% logic growth (2nm, 1.4nm pull-in), 75% memory growth. China still ~20% of sales. Stock up 117% YoY, 66% YTD, and the multiples debate is getting loud — but the rate of change is undeniably bullish.
“ASML expects sales of EUR11,500 million for the third quarter of 2026, 10.9% above consensus of EUR10,367 million, and a gross margin of 56.0% versus 52.1% consensus.”
Key risk: capacity buildout is a capex-heavy promise, and execution on 1.4nm pull-in matters. But the trajectory is clear — ASML owns the only game in town for leading-edge lithography. Hold your longs, trim into strength if you need to, but don’t short this momentum.
CANTOR STAYS NEUTRAL AT $175 — but the tape tells a different story. Stock off 33% from highs (vs. semi equipment group down just 21%). Orders are “unprecedented” YTD, with ~70% revs from advanced packaging. That’s real. But Cantor flags competitive heat from Onto and KLA in 2H. Meanwhile Evercore and Jefferies both went to $200, Stifel downgraded to Hold at $185 on valuation.
“Much of the order strength has already been contemplated within prior commentary.” — Cantor, playing the “already priced” card.
Stock at 30x 2027 EPS ($4.50-$5.00). That’s not expensive if the HBM ramp is real (orders >$105M, including $55M from an OSAT for AI and $50M+ from an HBM manufacturer). But 30x on peak-cycle numbers? Risky for a mid-cap inspection player. The bull case: orders keep accelerating through 2027. The bear: KLA/Onto eat CAMT’s lunch as packaging gets more complex. We lean neutral here — the pullback makes r/r better, but we’d want to see the next print confirm the backlog before stepping in.
BofA is ringing the register on Ericsson. PT cut to SEK77 from SEK88 (Maintain Underperform) after a Q2 revenue miss and Q3 guide below consensus — despite an EBITA beat that nobody cares about.
The thesis is simple: rising memory prices are hitting component costs while the RAN market stays flat. BofA cut EBITDA by 1-14% across FY26-28. The new PT uses a 6.0x EV/EBITDA multiple on FY27 — right in the middle of the stock’s historical 4-10x range. But at current EV/EBITDA of 8.6x, there’s still room to fall.
“The firm cited Ericsson’s second-quarter revenue miss and third-quarter guidance below consensus. The analyst pointed to rising component costs driven by elevated memory pricing as a challenge for Ericsson.”
Networks segment dragging (sales down on mix effects and tough comps). Cloud Software & Services showed a pulse with double-digit EBITDA margins, but not enough to move the needle. Cost pressures are the real tail risk here — management explicitly guided for component cost inflation to accelerate in coming quarters.
Reiterate Market Outperform. $315 PT. Andrew Boone at Citizens is leaning into the AWS narrative as the Q2 print approaches (July 30 — 15 days away). He sees revenue hitting the high end of guidance, with Q3 upside from full utilization, new capacity, and higher pricing. The key tension: AWS is raising prices on select EC2 instances (twice this year) to manage tight compute supply and data center inflation costs. That’s a pricing power signal, not a demand problem.
“AWS revenue growth to accelerate in 2027 as AI adoption ramps and the company benefits from progress with custom silicon, specifically Trainium.”
Citizens is ~$16B AHEAD of consensus on 2027 capex. They’re fine with that — they see the spend as necessary to meet AI-driven compute demand. The stock trades at 29.6x P/E with a PEG of 0.81, so the growth premium isn’t excessive yet. The non-core news (Loom for AWS, Claude gateway, Warner Bros adtech deal) are incremental positive signals for AWS ecosystem stickiness. No change to thesis — just steady conviction into the print.
IBM’s miss was messy — but the signal for security is clean. Barclays points out that clients shifted Q2 capex toward infrastructure purchases (servers, storage, firewalls) to lock in supply before price hikes. That dynamic already showed up in FTNT’s Q1 product acceleration, and pricing is following higher input costs. The Mythos-driven threat distraction is actually supporting security spending at the expense of other IT buckets — a tailwind for firewall vendors even as IBM itself lost deals.
"Barclays noted that firewall product growth for vendors like Fortinet accelerated in the first quarter and pricing is rising to reflect higher input costs."
Don’t overplay the IBM miss read-through — this is a cyclical/capex rotation story, not a macro rejection. FTNT sits right in the crosshairs of clients defending infrastructure budgets.
Mizuho cuts to Neutral, PT to $45. The downgrade is purely a deal call — not a fundamental deterioration. Since the SOLS/ESI merger announcement, ESI is down 7% and SOLS is off 21%. That’s a -21% print in the acquiring stub. The thesis: the combined company looks like pre-spin DuPont (diversified, not pure-play). Mizuho sees “limited operational dis-synergies” but thinks portfolio separation is a longer-term game. Low probability of a third-party bid, so don’t wait for a white knight.
“The combined company will resemble pre-spin DuPont, with a diversified portfolio spanning electronics and industrial end-markets.”
The rest of the Street is split. Freedom Broker also downgraded to Hold on that modest 15% premium. BMO reiterated Outperform at $45 — effectively saying the floor is the deal price. Truist upgraded SOLS to Buy on the post-announcement drop, not ESI. Net net: if you were holding ESI hoping for a pure-play electronics chemicals spin, that path is now gated by SOLS’s underperformance and a management team that explicitly doesn’t want to split quickly. The r/r skews negative until SOLS stabilizes or the combined entity proves it can de-merge faster than Mizuho expects.
Cantor sticks to Overweight, $175 PT. Sees a modest beat-and-raise next week. But near-term upside is capped until Farmer’s Branch ramps. Sub-$120 is the entry zone.
FORM trades at $116.74 – UP 218% Y/Y but still 27% BELOW THE 52-WEEK HIGH of $160.27. Cantor expects a Q2 print that clears the bar, then a pause. Manufacturing efficiency constraints limit the next leg. The Farmer’s Branch pilot line (Q4 2026) and 2027 ramp is the real catalyst.
“Cantor Fitzgerald views sub-$120 as an attractive entry point.”
The firm sees a trading range until that ramp kicks in. Longer-term, the 2030 target model gets a boost from HBM/DDR demand, share gains at Nvidia/AMD/ASICs, agentic AI CPU demand, and CPO. Demand across DRAM and flash is “increasingly robust.”
(Other analysts piled in after the Q1 beat – Stifel to $135, Northland to $118, Evercore to $155, Craig-Hallum to $175. Collective bullishness, but near-term patience required.)
DA Davidson standing pat: Buy, $96 target. No fireworks here — the call is entirely about visibility and steady-state execution. The firm sees SSNC printing a Q2 that meets or modestly beats on revenue ($1.66B, +8% y/y) and EBITDA ($656M, +39.6% margins). The narrative is a compounder, not a catalyst chaser.
“We forecast the company will meet or modestly exceed estimates for the quarter and anticipate management will affirm or modestly adjust prior 2026 guidance.”
Organic growth is anchored at ~5.2% constant-currency, with two small acquisitions adding ~$34-36M in revenue. The Q1 beat (revs +1% vs consensus, EPS +3%) already proved the engine is humming. The $1.5B buyback authorization is a backstop, not a near-term lever — expect it to be opportunistically deployed.
The bear case is that SSNC is boring. There’s no AI angle driving multiple expansion, no HFT-style acceleration — just a fintech/back-office infrastructure player grinding out mid-single-digit organic growth with margin expansion. The bull case is that boring works. In a world of whipsawing growth stocks, SSNC offers 8-10% EPS growth, a reasonable ~15x forward P/E, and a management team that under-promises and over-delivers with mechanical precision.
Bottom line: Not a home run, but a solid single. The stock drifts higher into earnings on repeatability. No reason to fade it.
Stifel stays Buy at $12, but this is a Hail Mary on margins, not growth. The 20% workforce cut (260 heads) is a necessary but painful step toward a Rule of 30 target in Q4 2027 (currently ~23). The problem: top-line decelerating to single digits in Q2 and through 2026. Street models only ~25 Rule by then. That means SPT needs >10 points of EBIT margin expansion from here — and it has to come from cutting costs, not scaling revenue.
The bull case rests entirely on the 77% gross margin giving operating leverage room to run. Stifel views this as "prudent." The bear case: you're asking a shrinking top line to fund AI product dev and upmarket sales while squeezing out 10+ margin points. That math works on a spreadsheet. In execution? Less certain.
“We believe this workforce reduction is a prudent step toward achieving the company’s fourth quarter 2027 Rule of 30 target.” — Stifel
Q1 EPS beat ($0.23 vs $0.16) was noise — revenue in line, guidance weak. The stock at $8.90 (down 54% YoY) already prices in a lot of failure. R/r? Depends on how much you trust the margin lever. Not a conviction name.
Stifel starts coverage with a Buy and C$100 PT — a 2.5x from here — betting the defense “New Space” pivot is the real catalyst that the market is ignoring. The stock sits at $37.92, 36% off its 52-week high, carrying $2.66B debt vs $2.53B market cap (debt/equity 7.1x). That leverage is the whole risk story, but Stifel sees Lightspeed as national critical infrastructure with government-backed debt, not just another LEO constellation. The bear case: New Street initiated with a Sell and $30 PT, arguing Telesat can’t compete on pricing against Starlink’s capacity advantage.
“Defense is being disrupted by private capital, Silicon Valley best-practices and a political shakeup in procurement. Telesat is a pure play on what is called New Space in the non-terrestrial sector.” — Greg MacDonald, Stifel
Bull case (Stifel) — Lightspeed’s B2B model (enterprise + defense) sidesteps Starlink’s consumer focus. Mil-Ka spectrum + sovereign Canadian domicile are structural moats. Catalysts: upside revisions from the ESCP-P military constellation, and a negotiated settlement on outstanding bondholder litigation. Debt is scary, but it’s government-backed and tied to critical infrastructure.
Bear case (New Street) — Capacity is king, and Telesat’s 198-satellite LEO plan pales next to Starlink’s thousands. Pricing pressure will crush margins. The financial reality: Q1 EPS of -C$3.04 vs -C$0.88 forecast — losses continue to widen. The $30 PT implies ~20% downside from here.
Verdict: High-conviction asymmetry if you believe the defense narrative triggers re-rating. But the balance sheet is the single biggest risk — you’re betting on a catalyst thesis to de-risk it. Not for the faint-hearted PM.
Cantor reiterates Overweight / $600 PT and names MKSI top pick in SMID-cap ahead of the July 29 Q2 print. That’s a bold call given the stock is already UP 238% Y/Y and 121% YTD. They see meaningful upside to guidance and consensus into CY27/28 – EPS estimates potentially hitting ~$20 and $26 versus consensus $15.22 and $17.32. That’s a 30-50% beat baked into their view.
The thesis is simple: MKSI is a subsystem supplier levered to wafer fab equipment inflection, which should drive fundamental outperformance vs. system suppliers. Add exposure to advanced substrates (tight supply/demand thanks to AI) and rapid deleveraging (EPS tailwind + expands investor base). The kicker – valuation. It trades at ~27x NTM consensus vs the semi equipment peer average of 39x. Cantor’s $600 target is 25x CY28 EPS discounted back.
“Rapid deleveraging offers an earnings per share tailwind and expands the potential investor base.”
That relative discount won’t last if the $20-$26 EPS numbers are real. The call is squarely a multiple re-rating story with earnings momentum as the catalyst.
Still the platformization play. Tigress lifts PT to $430 from undisclosed prior (stock at $355, +92% YTD, sniffing $368 high). The thesis hasn't changed: AI-native platform consolidation drives high-return growth, and the CyberArk identity deal is a near-term ROC drag for a long-term moat. Needham ($425), Evercore ($415) — PTs getting lifted across the board, all citing the same momentum in next-gen security.
"AI-native platformization positions the company as strategically advantaged in the agentic AI era."
The Q3 revenue beat (+2% vs consensus) and the string of raised targets tell you PMs are already positioned for this. Not much new here — just confirmation that the buy-and-hold crowd is still adding. Risk: the stock's already priced in a lot of the platform shift, but the rate of change on billings is what I'm watching next.
Cantor reiterates Neutral / $200 PT (stock at $209.68, DOWN 60% Y/Y). Channel checks are upbeat — elite partners see strong upmarket and multi-Hub momentum, and the Commerce Hub rebrand to Revenue Hub with CPQ functionality gets real praise. Breeze is improving but still not a driver. The checks give some near-term confidence, but Cantor isn't ready to upgrade.
"Given CPQ applicability across HubSpot’s installed base, the partners were all favorable on its impact for the second half of 2026 and 2027."
27 analysts have revised estimates upward, yet the stock is pinned near $210. Macquarie downgraded to Neutral citing growth deceleration (net new ARR below CC revenue growth). Stifel and Piper Sandler cut PTs but kept Buys — they see 18% CC growth as steady, not accelerating. Market is pricing in more deceleration than the channel checks suggest. Not sure we can read too much into a three-partner sample, but the CPQ tailwind into 2027 is a real hook for the upmarket push. Rate of change on growth remains the bogey.
NEEDHAM BUMPS PT TO $250 FROM $200, STAYS LONG — SHARES AT $136, NEAR 52-WEEK LOW. The call is about the intersection of AI and Starship execution. Grok 4.5 dropped July 8 — first-party AI model built on Cursor dev data. Doesn't match Anthropic or OpenAI yet, but puts the program back on track after Elon said they had to rebuild from scratch in March. That's the rate-of-change signal.
"The model does not quite match leading models from Anthropic or OpenAI but puts SpaceXAI back on track after Elon Musk said in March the company had to completely rebuild its AI program."
Other analysts are in the tent too — Evercore at $230, Stifel at $190, Raymond James at $800 (yes, $800 — they cite compression in Starship flight cadence). Deutsche Bank dropped a note suggesting orbital-terrestrial data center cost parity by early 2030s. That's the long TAM narrative.
Starship Flight 13 launches as early as July 16 — 20 full-size Starlink V3 test units to orbit. Needham sees AI model performance + Starship success as the dual unlock for TAM. Execution confidence is why they bumped the PT.
Bottom line: near-term price action is horrid (down 8% in a week, sitting on the 52-week low), but this is a bet on two catalysts that are both in the next 30 days. Risk/reward at these levels is asymmetric if you believe either thesis. I'd watch the launch window and any Grok 4.5 benchmark leaks for the next leg.
THE SETUP STINKS, BUT THE R/R IS BUILDING. Stock -32% since Q1 earnings (S&P +mid-singles). That’s a lot of pain for a business that just printed a 2030 framework. Guggenheim sticking with Buy / $120 – sees the key question as whether the April WSJ-reported targets ($78B rev, $9B ad, 38% margin, 410M subs) are still alive. At 1.2x PEG on adj EPS of $3.24 (ex WBD fee), the valuation is cheap if the framework holds.
BUT SENTIMENT IS HORRID. Guggenheim’s own survey shows NFLX as the #1 short idea into Q2 print. That’s a crowded trade. The three monitors: core engagement into 2H (revenue guide revisions, viewership data), new initiatives (TF1, short-form, MLB Home Run Derby costs), and the M&A vs. buyback tension after management said they’re building “M&A muscle” but also just authorized $25B in buybacks.
ANALYSTS ARE A MIXED BAG, NOT A CONSENSUS. Evercore Outperform / $115, BofA Buy / $125. Rosenblatt Neutral / $95. Morgan Stanley and KeyBanc cut targets to $90-92 but stay Overweight – both cite engagement concerns. The divergence is wide. The bull case: framework + buyback + cheap. The bear case: engagement deceleration + competition + ad ramp slower than hoped.
“The key question for investors is whether the 2030 growth framework reported by The Wall Street Journal on April 14, 2025 remains achievable.”
BOTTOM LINE: Earnings is a binary event. The stock has already de-rated hard. If Netflix guides in line or announces a material buyback, the short squeeze potential is real. If engagement numbers are soft and the framework gets pushed back, $90 is the next stop. This is a high-conviction risk/reward play – not a hold-through-the-noise.
AMAT – Bullish. WFE runway extends to $400-500B by 2030, with the $300B base case a near certainty. AMAT is the largest pure-play WFE vendor, levered to deposition, etch, and CMP. ASML's capacity expansion pulls through AMAT's tools as fabs build out. Top-line acceleration is intact. The broader semicap complex is re-rating after ASML's beat.
KLAC – Bullish. ASML's capacity expansion demands commensurate process control and inspection. KLAC dominates wafer inspection, critical for yield as EUV layers proliferate. EUV/DUV capacity growing ~30% annually means inspection intensity rises proportionally. Accelerating demand for inspection tools is a direct tailwind.
LRCX – Bullish. LRCX leads etch and deposition for 3D NAND and DRAM scaling. ASML's +75% memory revenue growth in 2026 implies significant downstream etch/deposition demand. Memory manufacturers are ramping capacity for HBM and high-density NAND — a direct demand pull for LRCX tools.
MU – Bullish/High. The $110B cap erase below $900 is purely mechanical (trailing stops after a massive rally). No fundamental driver. 85% gross margins, supply short through 2027+. Rubin memory BOM tripling to ~25% of total GPU cost. Customers pushing back on price hikes but AI demand is inelastic. This is a gift for disciplined buyers. China DRAM risk is 3-5 years away.
SKHY – Bullish/High. Violent drawdown in sympathy with MU – pure technical de-risking. Korean-listed shares amplified by leveraged ETFs. Fundamental demand from HBM and DRAM remains strong. SK Hynix is the HBM leader, with HBM3e ramping and HBM4 in development. ASML's memory growth directly supports SK Hynix capex. ADR premium controversy does not reflect underlying business health.
SNDK – Bullish/Medium. Biggest drawdown of the year, purely mechanical alongside MU/SKHY. NAND demand supported by KV cache offloading, exceeding expectations. DRAM-to-NAND substitution trend benefiting NAND vendors. NAND pivot makes sense if HDD is terminal, though 27-28 HAMR backlogs are strong. SNDK is well-positioned as a standalone NAND pure-play in an AI-driven storage cycle.
INTC – Bullish/Medium. High-NA EUV volume production for Panther Lake is a real milestone for the foundry turnaround. Nova Lake compute die shift from TSMC 60-70% to 10-20% suggests 18A maturity. 18A yields improving to 85%, design wins expanding (NVDA, AMD, MRVL, MSFT, MU, OpenAI). Skepticism persists on long-term node cadence, but near-term momentum is building.
GOOG – Bullish/High. Warren Buffett personally drove the GOOG investment, validating hyperscaler AI ROIC. GOOG backstopping ~$50B in AI commitments, yielding ~$100B in TPU revenue. Clear leader in energy strategy. Rate of change accelerating. Buffett's endorsement changes the narrative – the AI buildout is rational, not a bubble.
META – Bullish/High. Hyperion data center expanded to 5GW costing $50B+ (from $27B/2GW plan). Massive scale-up signals META is doubling down on AI infra. Pragmatic energy strategy (behind-the-meter gas with near-zero backup) gives speed advantage. Rate of change in capex accelerating.
NVDA – Bullish/High. Jensen explicitly denied Vera Rubin delay rumors – already in production, huge volumes incoming. Removes a key downside risk. CSP custom ASIC is a 2-3 year risk, but training moat remains strong. WFE demand extends through 2028, supporting NVDA's capacity to secure leading-edge nodes. Supply chain aligned for volume ramp.
TSM – Bullish/High. Q2 earnings tomorrow: revenue NT$1.27T, net profit expected +59% YoY. Gross margin could exceed 68%, AI revenue CAGR guidance expected to be raised from mid-to-high 50% to 70-80%. Five 2nm fabs ramping simultaneously. CoWoS packaging expansion remains a bottleneck. CY26 capex guide is the key data point — $420B+ expected.
AVGO – Bullish/High. Aehr's record $41M hyperscaler order confirms multi-gen custom AI ASIC programs moving to volume. TPU share defense intact at ~80% despite MediaTek entry. Custom silicon is expanding the pie, not just taking share from merchant GPUs. AVGO benefits from increasing custom silicon intensity across all hyperscalers.
AEHR – Bullish/High. Record $41M production order from lead hyperscaler for package-level burn-in systems. 1st device in production, 2nd device with twice the power ramping, 3rd in design. Rate of change accelerating. Wafer-level burn-in adoption increasing – a top-tier AI processor benchmark showed better than package-level results. Shift to wafer-level screening is the fastest-growing test segment.
ARM – Bullish/High. CEO confirms AI infra supply-constrained for 2-3 years across chips, data center, energy, labor. Data center business about to become ARM's largest segment. Revenue mix shift from mobile to data center IP. CSP custom ASICs based on ARM (Graviton) expand royalty opportunity. Rate of change accelerating.
PYPL – Bullish/Medium. Stripe and Advent made a joint takeover bid at $60.50/share, valuing company over $53B. PYPL surged +16.8%. Bid validates deep value in fintech, but price may be too low. Call volume surged ahead of report – possible insider trading. Antitrust risk is key – DOJ/EU review will be a long process. If deal breaks, PYPL retraces.
CRWV – Bearish/Medium. -50% LTM, -5% YTD. Neoclouds under extreme market skepticism. Contracted power scaled to 3.5GW but stalled after Q3 2025 bond sell-off froze high-yield for the sector. Non-IG neoclouds disadvantaged. Expect bankruptcies or absorption. Capital access issues persist despite strong AI demand.
NBIS – Neutral/Low. Introduced asset-light AI cloud model through infrastructure partnerships. Higher-margin, faster-growth model than other neoclouds. Market values NBIS at 20% more than CRWV, which some find offensive. Transition from neocloud to SaaS-like model is unproven at scale. Execution risk is high.